Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asfandyar Mufti

Showing results (131-140 of 150) with videos related to

Pageof 15
Sort By:
JAAD International|July 6, 2023
Real-world effectiveness and safety of risankizumab in patients with plaque psoriasis in whom guselkumab failed recently: A multicenter retrospective study of switching within the interleukin-23 inhibitor classAhmed Bagit, Khalad Maliyar, Jorge R Georgakopoulos, et al.
JAAD International|May 22, 2024
Outcomes of systemic Janus kinase inhibitors following prior dupilumab use for atopic dermatitis: An evidence-based reviewSiddhartha Sood, Ahmed Bagit, Martin Heung, et al.
Journal of the American Academy of Dermatology|September 18, 2024
Systemic Janus kinase inhibitor treatment for vitiligo: An evidence-based reviewSiddhartha Sood, Jaymie Varenbut, Ahmed Bagit, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 22, 2014
Whole-body radiation dosimetry of 11C-carbonyl-URB694: a PET tracer for fatty acid amide hydrolaseIsabelle Boileau, Peter M Bloomfield, Pablo Rusjan, et al.
Journal of Cutaneous Medicine and Surgery|October 25, 2024
Treatment Outcomes in Extramammary Paget's Disease: A Systematic ReviewRyan S Q Geng, Siddhartha Sood, Jihad Waked, et al.
Journal of Cutaneous Medicine and Surgery|February 15, 2025
Management of Chronic Prurigo and Prurigo Nodularis with Systemic Janus Kinase Inhibitors: An Evidence-Based ReviewSiddhartha Sood, Ryan S Q Geng, Martin Heung, et al.
Journal of the American Academy of Dermatology|October 25, 2021
Management of pediatric generalized pustular psoriasis using biologics: An evidence-based reviewMuskaan Sachdeva, Brian D Rankin, Asfandyar Mufti, et al.
Journal of Cutaneous Medicine and Surgery|December 27, 2025
Response to Reader Comment on: Navigating Bullous Pemphigoid: Consensus Recommendations for Diagnosis and Management-A Canadian PerspectiveFiona E Lovegrove, Maxwell B Sauder, Asfandyar Mufti, et al.
Journal of Cutaneous Medicine and Surgery|July 16, 2025
Navigating Bullous Pemphigoid: Consensus Recommendations for Diagnosis and Management-A Canadian PerspectiveFiona E Lovegrove, Maxwell B Sauder, Asfandyar Mufti, et al.
Journal of Cutaneous Medicine and Surgery|September 30, 2021
Incidence of COVID-19 in Patients With Chronic Idiopathic Urticaria and Asthma on Omalizumab: A Multicentre Retrospective Cohort StudyAbrahim Abduelmula, Jorge R Georgakopoulos, Asfandyar Mufti, et al.
Pageof 15

Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
JAAD International|July 6, 2023
Real-world effectiveness and safety of risankizumab in patients with plaque psoriasis in whom guselkumab failed recently: A multicenter retrospective study of switching within the interleukin-23 inhibitor classAhmed Bagit, Khalad Maliyar, Jorge R Georgakopoulos, et al.
JAAD International|May 22, 2024
Outcomes of systemic Janus kinase inhibitors following prior dupilumab use for atopic dermatitis: An evidence-based reviewSiddhartha Sood, Ahmed Bagit, Martin Heung, et al.
Journal of the American Academy of Dermatology|September 18, 2024
Systemic Janus kinase inhibitor treatment for vitiligo: An evidence-based reviewSiddhartha Sood, Jaymie Varenbut, Ahmed Bagit, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 22, 2014
Whole-body radiation dosimetry of 11C-carbonyl-URB694: a PET tracer for fatty acid amide hydrolaseIsabelle Boileau, Peter M Bloomfield, Pablo Rusjan, et al.
Journal of Cutaneous Medicine and Surgery|October 25, 2024
Treatment Outcomes in Extramammary Paget's Disease: A Systematic ReviewRyan S Q Geng, Siddhartha Sood, Jihad Waked, et al.
Journal of Cutaneous Medicine and Surgery|February 15, 2025
Management of Chronic Prurigo and Prurigo Nodularis with Systemic Janus Kinase Inhibitors: An Evidence-Based ReviewSiddhartha Sood, Ryan S Q Geng, Martin Heung, et al.
Journal of the American Academy of Dermatology|October 25, 2021
Management of pediatric generalized pustular psoriasis using biologics: An evidence-based reviewMuskaan Sachdeva, Brian D Rankin, Asfandyar Mufti, et al.
Journal of Cutaneous Medicine and Surgery|December 27, 2025
Response to Reader Comment on: Navigating Bullous Pemphigoid: Consensus Recommendations for Diagnosis and Management-A Canadian PerspectiveFiona E Lovegrove, Maxwell B Sauder, Asfandyar Mufti, et al.
Journal of Cutaneous Medicine and Surgery|July 16, 2025
Navigating Bullous Pemphigoid: Consensus Recommendations for Diagnosis and Management-A Canadian PerspectiveFiona E Lovegrove, Maxwell B Sauder, Asfandyar Mufti, et al.
Journal of Cutaneous Medicine and Surgery|September 30, 2021
Incidence of COVID-19 in Patients With Chronic Idiopathic Urticaria and Asthma on Omalizumab: A Multicentre Retrospective Cohort StudyAbrahim Abduelmula, Jorge R Georgakopoulos, Asfandyar Mufti, et al.
Pageof 15